Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion.
- 1 January 2000
- journal article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 18 (4) , 303-308
- https://doi.org/10.1023/a:1011085820250
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitorJournal of Clinical Investigation, 1999
- Localization of Tissue Factor in Actin-Filament-Rich Membrane Areas of Epithelial CellsExperimental Cell Research, 1999
- Regulation of ProMMP-1 and ProMMP-3 Activation by Tissue Factor Pathway Inhibitor-2/Matrix-Associated Serine Protease InhibitorBiochemical and Biophysical Research Communications, 1999
- The Angiogenic Effect of Tissue Factor on Tumors and WoundsSeminars in Thrombosis and Hemostasis, 1998
- Assignment of the Human PP5/TFPI-2 Gene to 7q22 by FISH and PCR-based Human/Rodent Cell Hybrid Mapping Panel AnalysisGenomics, 1996
- Inhibitory Properties of Separate Recombinant Kunitz‐Type‐Protease‐Inhibitor Domains from Tissue‐Factor‐Pathway InhibitorEuropean Journal of Biochemistry, 1996
- Inhibitory Properties of a Novel Human Kunitz-Type Protease Inhibitor Homologous to Tissue Factor Pathway InhibitorBiochemistry, 1996
- The plasminogen-plasmin system in malignancyCancer and Metastasis Reviews, 1992
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970